Business · 16/08/1994Updated: 10/16/2026 · 1 min read

National Cancer Institute Seeks Cooperative Research Agreement for Monoclonal Antibodies Development

Summary

The National Cancer Institute (NCI) is seeking a pharmaceutical or biotechnology company to develop a panel of monoclonal antibodies against cripto-1 (CR-1), a protein that may play a role in tumor cell growth and cancer development.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Healthcare Business News Business Technology News Global Markets News Trade Regulation News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Business · 9/15/2026

National Cancer Institute Considers Exclusive Patent License for Engineered Cell Therapies for HPV 16 E6-Expressing Cancers

The National Cancer Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to MedGene Therapeutics, Inc., a Maryland-based company, to develop and commercialize engineered cell therapies for treating cancers caused by the HPV 16 E6 gene.

Read summary →

Business · 10/5/2026

CDC Invites Public Comment on Proposed Data Collection for Public Health Crisis Response

The Centers for Disease Control and Prevention (CDC) is seeking public feedback on a proposed data collection project, titled Public Health Crisis Response (PHCR) Cooperative Agreement, which aims to rapidly fund public health programs responding to major emergencies and crises, as required by the Paperwork Reduction Act of 1995.

Read summary →

Business · 9/28/2026

CDC Invites Public Comment on Proposed Data Collection for Public Health Emergency Preparedness

The Centers for Disease Control and Prevention (CDC) is seeking public input on a proposed data collection project, titled Public Health Emergency Preparedness (PHEP) Cooperative Agreement, as part of its efforts to reduce public burden and maximize the utility of government information, in accordance with the Paperwork Reduction Act of 1995.

Read summary →

Business · 9/16/2026

Government-Owned Inventions; Availability for Licensing

The National Institute of Allergy and Infectious Diseases (NIAID) is giving notice of a government-owned invention available for licensing to achieve commercialization of federally funded research results.

Read summary →

Business · 9/15/2026

National Cancer Institute Announces Closed Meeting

The National Cancer Institute has issued a notice regarding a closed meeting, which is not open to the public.

Read summary →

Business · 9/14/2026

NIH Proposes Enhanced Biosafety Policy for Biohazard Research

The National Institutes of Health is seeking public input on a new, comprehensive biosafety policy aimed at strengthening oversight and keeping pace with evolving biohazard risks, with the goal of ensuring gold-standard science under gold-standard biosafety conditions.

Read summary →